170 related articles for article (PubMed ID: 35738865)
21. PDGF Engages an E2F-USP1 Signaling Pathway to Support ID2-Mediated Survival of Proneural Glioma Cells.
Rahme GJ; Zhang Z; Young AL; Cheng C; Bivona EJ; Fiering SN; Hitoshi Y; Israel MA
Cancer Res; 2016 May; 76(10):2964-76. PubMed ID: 26951930
[TBL] [Abstract][Full Text] [Related]
22. Development of genetically flexible mouse models of sarcoma using RCAS-TVA mediated gene delivery.
Kabaroff L; Gupta A; Menezes S; Babichev Y; Kandel RC; Swallow CJ; Dickson BC; Gladdy RA
PLoS One; 2014; 9(4):e94817. PubMed ID: 24733554
[TBL] [Abstract][Full Text] [Related]
23. Mesenchymal stem cells display tumor-specific tropism in an RCAS/Ntv-a glioma model.
Doucette T; Rao G; Yang Y; Gumin J; Shinojima N; Bekele BN; Qiao W; Zhang W; Lang FF
Neoplasia; 2011 Aug; 13(8):716-25. PubMed ID: 21847363
[TBL] [Abstract][Full Text] [Related]
24. Overexpression of CDC2/CyclinB1 in gliomas, and CDC2 depletion inhibits proliferation of human glioma cells in vitro and in vivo.
Chen H; Huang Q; Dong J; Zhai DZ; Wang AD; Lan Q
BMC Cancer; 2008 Jan; 8():29. PubMed ID: 18230152
[TBL] [Abstract][Full Text] [Related]
25. miR-139 Functions as An Antioncomir to Repress Glioma Progression Through Targeting IGF-1 R, AMY-1, and PGC-1β.
Wang H; Yan X; Ji LY; Ji XT; Wang P; Guo SW; Li SZ
Technol Cancer Res Treat; 2017 Aug; 16(4):497-511. PubMed ID: 26868851
[TBL] [Abstract][Full Text] [Related]
26. Inducing primary brainstem gliomas in genetically engineered mice using RCAS/TVA retroviruses and Cre/loxP recombination.
Weidenhammer LB; Liu HQ; Luo L; Williams NT; Deland K; Kirsch DG; Reitman ZJ
STAR Protoc; 2023 Mar; 4(1):102094. PubMed ID: 36853662
[TBL] [Abstract][Full Text] [Related]
27. Regulated ATF5 loss-of-function in adult mice blocks formation and causes regression/eradication of gliomas.
Arias A; Lamé MW; Santarelli L; Hen R; Greene LA; Angelastro JM
Oncogene; 2012 Feb; 31(6):739-51. PubMed ID: 21725368
[TBL] [Abstract][Full Text] [Related]
28. A network model of a cooperative genetic landscape in brain tumors.
Bredel M; Scholtens DM; Harsh GR; Bredel C; Chandler JP; Renfrow JJ; Yadav AK; Vogel H; Scheck AC; Tibshirani R; Sikic BI
JAMA; 2009 Jul; 302(3):261-75. PubMed ID: 19602686
[TBL] [Abstract][Full Text] [Related]
29. Glioma stem cells are more aggressive in recurrent tumors with malignant progression than in the primary tumor, and both can be maintained long-term in vitro.
Huang Q; Zhang QB; Dong J; Wu YY; Shen YT; Zhao YD; Zhu YD; Diao Y; Wang AD; Lan Q
BMC Cancer; 2008 Oct; 8():304. PubMed ID: 18940013
[TBL] [Abstract][Full Text] [Related]
30. The contribution of tumor and host tissue factor expression to oncogene-driven gliomagenesis.
Magnus N; Meehan B; Garnier D; Hashemi M; Montermini L; Lee TH; Milsom C; Pawlinski R; Ohlfest J; Anderson M; Mackman N; Rak J
Biochem Biophys Res Commun; 2014 Nov; 454(2):262-8. PubMed ID: 25450387
[TBL] [Abstract][Full Text] [Related]
31. Lrig1 is a haploinsufficient tumor suppressor gene in malignant glioma.
Mao F; Holmlund C; Faraz M; Wang W; Bergenheim T; Kvarnbrink S; Johansson M; Henriksson R; Hedman H
Oncogenesis; 2018 Feb; 7(2):13. PubMed ID: 29391393
[TBL] [Abstract][Full Text] [Related]
32. PDGF autocrine stimulation dedifferentiates cultured astrocytes and induces oligodendrogliomas and oligoastrocytomas from neural progenitors and astrocytes in vivo.
Dai C; Celestino JC; Okada Y; Louis DN; Fuller GN; Holland EC
Genes Dev; 2001 Aug; 15(15):1913-25. PubMed ID: 11485986
[TBL] [Abstract][Full Text] [Related]
33. RAD51 can inhibit PDGF-B-induced gliomagenesis and genomic instability.
Westermark UK; Lindberg N; Roswall P; Bråsäter D; Helgadottir HR; Hede SM; Zetterberg A; Jasin M; Nistér M; Uhrbom L
Neuro Oncol; 2011 Dec; 13(12):1277-87. PubMed ID: 21926087
[TBL] [Abstract][Full Text] [Related]
34. GFAP promoter driven transgenic expression of PDGFB in the mouse brain leads to glioblastoma in a Trp53 null background.
Hede SM; Hansson I; Afink GB; Eriksson A; Nazarenko I; Andrae J; Genove G; Westermark B; Nistér M
Glia; 2009 Aug; 57(11):1143-53. PubMed ID: 19115382
[TBL] [Abstract][Full Text] [Related]
35. Corrigendum to: Novel cancer gene discovery using a forward genetic screen in RCAS-PDGFB-driven gliomas.
Neuro Oncol; 2023 Apr; 25(4):810. PubMed ID: 36805975
[No Abstract] [Full Text] [Related]
36. Platelet-derived growth factor in human glioma.
Westermark B; Heldin CH; Nistér M
Glia; 1995 Nov; 15(3):257-63. PubMed ID: 8586462
[TBL] [Abstract][Full Text] [Related]
37. Gliomas in children and adolescents: investigation of molecular alterations with a potential prognostic and therapeutic impact.
Cabral de Carvalho Corrêa D; Tesser-Gamba F; Dias Oliveira I; Saba da Silva N; Capellano AM; de Seixas Alves MT; Dastoli PA; Cavalheiro S; Caminada de Toledo SR
J Cancer Res Clin Oncol; 2022 Jan; 148(1):107-119. PubMed ID: 34626238
[TBL] [Abstract][Full Text] [Related]
38. Insertional oncogenesis by non-acute retroviruses: implications for gene therapy.
Fan H; Johnson C
Viruses; 2011 Apr; 3(4):398-422. PubMed ID: 21994739
[TBL] [Abstract][Full Text] [Related]
39. Dose-dependent effects of platelet-derived growth factor-B on glial tumorigenesis.
Shih AH; Dai C; Hu X; Rosenblum MK; Koutcher JA; Holland EC
Cancer Res; 2004 Jul; 64(14):4783-9. PubMed ID: 15256447
[TBL] [Abstract][Full Text] [Related]
40. A Novel Mouse Model of Diffuse Intrinsic Pontine Glioma Initiated in Pax3-Expressing Cells.
Misuraca KL; Hu G; Barton KL; Chung A; Becher OJ
Neoplasia; 2016 Jan; 18(1):60-70. PubMed ID: 26806352
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
